Keatinge-Clay Adrian, Miyazawa Takeshi
UT Austin.
Res Sq. 2025 Jan 8:rs.3.rs-5640596. doi: 10.21203/rs.3.rs-5640596/v1.
While engineering modular polyketide synthases (PKSs) using the recently updated module boundary has yielded libraries of triketide-pentaketides, this strategy has not yet been applied to the combinatorial biosynthesis of macrolactones or macrolide antibiotics. We developed a 2-plasmid system for the construction and expression of PKSs and employed it to obtain a refactored pikromycin synthase in that produces 85 mg of narbonolide per liter of culture. The replacement, insertion, deletion, and mutagenesis of modules enabled access to hexaketide, heptaketide, and octaketide derivatives. Supplying enzymes for desosamine biosynthesis and transfer enabled production of narbomycin, pikromycin, YC-17, methymycin, and 6 derivatives thereof. Knocking out pathways competing with desosamine biosynthesis and supplying the editing thioesterase PikAV boosted the titer of narbomycin 55-fold to 37 mgL. The replacement of the 3rd pikromycin module with its 5th yielded a new macrolide antibiotic and demonstrates how libraries of macrolide antibiotics can be readily accessed.
虽然利用最近更新的模块边界对模块化聚酮合酶(PKS)进行工程改造已产生了三酮 - 五酮化合物库,但该策略尚未应用于大环内酯或大环内酯类抗生素的组合生物合成。我们开发了一种用于构建和表达PKS的双质粒系统,并利用它获得了一种经过重构的苦霉素合酶,该酶每升培养物可产生85毫克纳波内酯。模块的替换、插入、缺失和诱变能够获得六酮、七酮和八酮衍生物。提供去氧氨基糖生物合成和转移所需的酶能够生产纳波霉素、苦霉素、YC - 17、酒霉素及其6种衍生物。敲除与去氧氨基糖生物合成竞争的途径并提供编辑硫酯酶PikAV可将纳波霉素的产量提高55倍,达到37毫克/升。将苦霉素的第3个模块替换为第5个模块产生了一种新的大环内酯类抗生素,并展示了如何轻松获得大环内酯类抗生素库。